Be PatientTilray has done lots of great things for investors over the last year. Acquistions, new product releases, cost-savings etc. Everything is outlined in their Press Releases and QTR reports.
Their alchol sales alone made a VERY notable jump on last report and (personally) I am optimistic they will continue to do well in the drink market with the RIFF products, their Alchol / Craft Beers sales etc but most notable, their 100% ownership in Truss now (some of my personnal favorite infused drinks).
Their Canadian Cannabis sales are doing very well. They have a strong market share there in a market space still cluttered up with smaller players (that will correct itself over time) and they are making headway overseas.
The US will "eventually" legalize IMHO, it's a "WHEN" not an "IF" and when it does Tilray will likely leverage their New York Headquarters and launch sales in relatively short-order south of the border.
Rome wasn't built in a day but when it was built, those who showed up last payed the highest price for a position -> That's part of Supply / Demand.
Always DYODD + Be Patient.
GLTA